Technologies related to Cancer

Efficient Cell-Free Production of Papillomavirus Gene Transfer Vectors
Ref: E-298-2016/0 | Updated: Mar 14, 2018
Methods for Single Cell Analysis of the Epigenome, Transcriptome, and Genome
Ref: E-069-2017/0 | Updated: Mar 13, 2018
Cancer-reactive T cells from Peripheral Blood
Ref: E-149-2015/0 | Updated: Dec 18, 2017
Derivation of Novel Murine Metastatic Pancreatic Adenocarcinoma Cell Lines to Generate Orthotopic Allograft Mouse Models Useful for Preclinical Testing
Ref: E-250-2017/0 | Updated: Dec 15, 2017
MADCO-Accelerated Multidimensional Diffusion MRI
Ref: E-173-2016/0 | Updated: Dec 14, 2017
Stable Cell Line for Enhanced Expression and Production of Recombinant Human Tissue Inhibitor of Metalloproteinase-2 (TIMP-2)
Ref: E-216-2017/0 | Updated: Dec 5, 2017
T Cell Receptors (TCRs) Targeting KRAS Mutants for Cancer Immunotherapy/Adoptive Cell Therapy
Ref: E-180-2015/0 | Updated: Dec 4, 2017
CXCR1 - Human IL-8 Receptor cDNA
Ref: B-004-1995/0 | Updated: Dec 4, 2017
Human Single Domain Antibodies Targeting CD16A to Mediate ADCC
Ref: E-214-2016/0 | Updated: Nov 29, 2017
Non-invasive Methods for Characterizing Adrenocortical Tumors
Ref: E-193-2015/0 | Updated: Nov 22, 2017
Niclosamide for Treating Adrenocortical Cancer (ACC)
Ref: E-089-2016/0 | Updated: Nov 22, 2017
Antibodies and CARs Targeting FLT3 for the Treatment of Acute Myeloid Leukemia and Acute Lymphoid Leukemia
Ref: E-014-2017/0 | Updated: Nov 29, 2017
MYC-G-Quadruplex Stabilizing Small Molecules and Their Use
Ref: E-053-2015/0 | Updated: Nov 22, 2017
Combination Cancer Therapy with HDAC Inhibitors
Ref: E-065-2016/0 | Updated: Nov 22, 2017
Antibody Targeting PD1 for Cancer Immunotherapy
Ref: E-167-2016/0 | Updated: Nov 29, 2017
Clinical Outcome Predictors for Mantle Cell Lymphoma
Ref: E-131-2016/0 | Updated: Nov 21, 2017
Hypoxia Inducible Factor 1 (HIF-1) Inhibitors
Ref: E-115-2015/0 | Updated: Nov 20, 2017
Functionally-Interdependent Shape-Switching Nucleic Acid Nanoparticles
Ref: E-277-2016/0 | Updated: Nov 17, 2017
Methods of Producing Effective T-cell Populations Using Akt Inhibitors
Ref: E-013-2016/0 | Updated: Nov 13, 2017
A Rapid Method of Isolating Neoantigen-specific T Cell Receptor Sequences
Ref: E-067-2017/0 | Updated: Oct 10, 2017
Clinical Imaging with Acoustic Wave or Photoacoustic Tomosynthesis
Ref: E-114-2016/0 | Updated: Oct 10, 2017
Gene-based Diagnostic Predicts Patient Response to Cancer Immunotherapy
Ref: E-022-2017/0 | Updated: Nov 16, 2017
Near-IR Light-cleavable Conjugates and Conjugate Precursors
Ref: E-245-2016/0 | Updated: Oct 4, 2017
Human and Veterinary Cancer Therapeutic Agent Utilizing Anthrax Toxin-Based Technology
Ref: E-120-2013/0 | Updated: Oct 2, 2017
Evans Blue Dye Derivatives for Serum Albumin Labeling
Ref: E-099-2015/0 | Updated: Aug 24, 2017
Direct Reading Detection Kits for Surface Contamination by Anti-Neoplastic (Anti-Cancer) Drugs
Ref: E-162-2013/0 | Updated: Aug 31, 2017
Engineered Anthrax Toxin Variants that Target Cancer
Ref: E-246-2012/0 | Updated: Jul 6, 2017
Multimeric Protein Toxins to Target Cells Having Multiple Identifying Characteristics
Ref: E-059-2004/0 | Updated: Jul 6, 2017
Human and Veterinary Cancer Therapeutic Agent Utilizing Anthrax Toxin-Based Technology
Ref: E-293-1999/0 | Updated: Jul 6, 2017
Use of Heterodimeric IL-15 in Adoptive Cell Transfer
Ref: E-132-2016/2 | Updated: Oct 12, 2017
Extracellular Vesicles, Methods of Making Them, and Methods of Reducing Liver Uptake of Extracellular Vesicles
Ref: E-083-2016/0 | Updated: Dec 7, 2017
Computer-Aided Diagnostic for Use in Multiparametric MRI for Prostate Cancer
Ref: E-183-2016/0 | Updated: Jun 23, 2017
Serum Inflammatory Markers as Classifiers of Lung Cancer Mortality
Ref: E-283-2016/0 | Updated: Jun 16, 2017
Treatment of Neurodegenerative Diseases and Premature Aging by Modulating the Expression of P53 Isoform
Ref: E-088-2015/0 | Updated: May 17, 2017
Efficient mRNA-Based Genetic Engineering of Human NK Cells with High-Affinity CD16 and CCR7
Ref: E-036-2015/0 | Updated: May 17, 2017
T-cells Transduced with HLA A11 restricted CT-RCC HERV-E reactive TCR to Treat Patients with ccRCC
Ref: E-120-2016/0 | Updated: May 17, 2017
cGAP-PNA Multivalent Ligand Display at the Nanoscale
Ref: E-761-2013/0 | Updated: Apr 18, 2017
Devices for Improved Tissue Cryopreservation and Recovery
Ref: E-094-2016/0 | Updated: Apr 18, 2017
Tg(MMTV-Cre)#Mam Mouse Model for Developmental Biology, Hepatology, and Oncology Studies
Ref: E-113-2012/0 | Updated: Apr 17, 2017
New T-cell Immunotherapy That Targets Aggressive Epithelial Tumors
Ref: E-153-2016/0 | Updated: Mar 3, 2017
A New Class of Stable Heptamethine Cyanine Fluorophores and Biomedical Applications Thereof
Ref: E-271-2014/0 | Updated: Nov 22, 2017
Anti-CD133 Monoclonal Antibodies as Cancer Therapeutics
Ref: E-025-2015/0 | Updated: Feb 13, 2017
Anti-PY1235-MET Immunological Binding Reagent as Cancer Diagnostic
Ref: E-130-2016/0 | Updated: Feb 13, 2017
Deuterium Magnetic Resonance Imaging (dMRI) for In Vivo Visualization of Rapidly-Dividing Cells
Ref: E-188-2016/0 | Updated: Feb 7, 2017
Genetically Engineered Mouse-Derived Allograft for Use in Preclinical Studies of Metastatic Melanoma Therapies
Ref: E-291-2015/0 | Updated: Nov 29, 2016
Gene Signature Predictive of Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization (TACE)
Ref: E-101-2016/0 | Updated: Nov 17, 2016
Non-invasive Pan-Cancer Detection Method
Ref: E-177-2015/0 | Updated: Nov 8, 2016
Immunotoxins with Increased Stability for Cancer Therapy
Ref: E-157-2016/0 | Updated: Sep 6, 2017
Detection of Colorectal Cancer Using Two Heme-Related Molecules in Human Feces
Ref: E-198-2014/0 | Updated: Aug 30, 2016
Bag6 Polyclonal Antibodies That Recognize Human Bag6 Protein
Ref: E-077-2015/0 | Updated: Sep 8, 2016
Human Monoclonal Antibodies Targeting Glypican-2 in Neuroblastoma
Ref: E-211-2016/0 | Updated: Aug 8, 2016
Novel Metastatic Serous Epithelial Ovarian Cancer (SEOC) Mouse Models, Cell Lines, and Orthotopic Models Useful for Biomarker Discovery and Preclinical Testing
Ref: E-069-2012/0 | Updated: Jul 26, 2016
Shark Antibodies that Target Tumor and Viral Antigens
Ref: E-113-2016/0 | Updated: Jul 7, 2016
Long Acting Therapeutic Conjugates with Evans Blue
Ref: E-143-2015/0 | Updated: Jun 27, 2016
Anti- B-Cell Maturation Antigen Antibodies for Developing Cancer Therapeutics
Ref: E-010-2016/0 | Updated: Jun 27, 2016
Murine Cell Models for Metastatic Squamous Cell Carcinoma
Ref: E-213-2016/0 | Updated: Jun 22, 2016
Chimeric Antigen Receptors to CD276 for Treating Cancer
Ref: E-243-2015/0 | Updated: May 25, 2016
Polyclonal Anti-rat Acetylserotonin Methyl Transferase (ASMT)
Ref: E-059-2016/0 | Updated: Apr 26, 2016
A Novel Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treatment of CD30+ Lymphoma
Ref: E-001-2016/0 | Updated: Jan 14, 2016
Monoclonal Antibodies Fibroblast Growth Factor Receptor 4 (FGFR4) and Methods for Their Use
Ref: E-264-2015/0 | Updated: Jan 14, 2016
Improved Production of Prenylated Protein in Insect Cells
Ref: E-009-2015/0 | Updated: Jan 14, 2016
Metallic Nanoparticles for Photothermal Therapy
Ref: E-158-2015/0 | Updated: Jan 4, 2016
Thalidomide Analogs that Inhibit Inflammation and Angiogenesis
Ref: E-208-2015/0 | Updated: Jan 4, 2016
Assays for Measuring and Quantifying DNA Damage from Ionizing Radiation, Chemotherapeutic Agents, and Environmental Agents
Ref: E-276-2014/0 | Updated: Dec 1, 2015
Device for Selectively Removing Cells from a Biological Sample
Ref: E-045-2014/0 | Updated: Nov 30, 2015
SIRT1 KO Human Cell Lines Generated by CRISPR/Cas9-mediated DNA Editing
Ref: E-184-2015/0 | Updated: Nov 30, 2015
A Genetic System in Yeast for Functional Identification of Human p53 Mutations
Ref: E-183-1999/0 | Updated: Sep 9, 2015
Pseudomonas Exotoxin A with Modified Furin Cleavage Site
Ref: E-197-2015/0 | Updated: Sep 6, 2017
Genome Wide DNase I Hypersensitive Sites Detection in Formalin-Fixed Paraffin-Embedded Single Cells
Ref: E-254-2014/0 | Updated: Aug 17, 2015
Anti-CD47 Antibodies for the Treatment of Cancer
Ref: E-263-2014/0 | Updated: Sep 10, 2015
Rabbit Antisera to Various Matrix, Matricellular, and Other Secreted Proteins
Ref: E-135-2008/0 | Updated: Aug 11, 2015
Modified AAV5 Vectors for Enhanced Transduction and Reduced Antibody Neutralization
Ref: E-097-2015/0 | Updated: Nov 1, 2017
A Novel Adeno-Associated Virus for Gene Therapy
Ref: E-175-2015/0 | Updated: Nov 1, 2017
Bispecific Chimeric Antigen Receptors to CD22 and CD19 for Treating Hematological Cancers
Ref: E-106-2015/0 | Updated: Feb 9, 2017
Method of Treating Fumarate Hydratase-deficient Kidney Cancer
Ref: E-104-2014/0 | Updated: Sep 10, 2015
Boron Amino Acid Mimetics for PET Imaging of Cancer
Ref: E-135-2015/0 | Updated: Jun 29, 2015
Device for Selective Partitioning of Frozen Cellular Products
Ref: E-173-2009/0 | Updated: Jun 29, 2015
Novel Furoquinolinediones as Inhibitors of TDP2 and Their Potential Use to Treat Cancer
Ref: E-275-2014/0 | Updated: Nov 22, 2017
A Novel T Cell Therapy Against Patient-Specific Cancer Mutations
Ref: E-229-2014/0 | Updated: Mar 29, 2017
A Novel, Personalized T Cell Therapy: T-Cell Receptor Engineered T Cells Targeting Tumor Specific Mutations
Ref: E-233-2014/0 | Updated: Mar 29, 2017
Novel Cancer Immunotherapy: HLA-A11 Restricted T Cell Receptor That Recognizes G12D Variant of Mutated KRAS
Ref: E-028-2015/0 | Updated: Oct 13, 2015
Novel Immunotherapy for Cancer Treatment: Chimeric Antigen Receptors Targeting CD70 Antigen
Ref: E-021-2015/0 | Updated: Oct 13, 2015
IFN Gamma for Reducing Adverse Ocular Side Effects of MEK-Inhibitor Therapy in Cancer
Ref: E-248-2012/0 | Updated: Jul 1, 2015
CXCR4 Reduction Leads to Enhancement of Engraftment of Hematopoietic Stem Cells
Ref: E-173-2014/0 | Updated: Jul 1, 2015
Systems and Devices for Training and Imaging an Awake Test Animal
Ref: E-043-2015/0 | Updated: May 2, 2017
GTF2I Mutations as Genetic Marker for Prognosis of Thymic Malignancies
Ref: E-109-2014/0 | Updated: Jul 1, 2015
T Cell-Based Adoptive Transfer Immunotherapy for Polyomavirus-Associated Pathologies
Ref: E-166-2014/0 | Updated: Sep 12, 2017
89Zr-Oxine Complex for In Vivo PET Imaging of Labelled Cells and Associated Methods
Ref: E-080-2014/0 | Updated: Dec 2, 2015
Polyketal Nanoparticle Delivery of CpG Oligodeoxynucleotide for Treatment of Lung Cancer
Ref: E-159-2014/0 | Updated: Jan 13, 2015
Highly Sensitive Tethered-Bead Immune Sandwich Assay
Ref: E-188-2014/0 | Updated: Jan 13, 2015
Aza-Englerin Analogues - Novel Natural Product-Based Nitrogen-Containing Anti-Cancer Agents
Ref: E-090-2014/0 | Updated: Jan 13, 2015
Octopod (8-pointed star-shape) Iron Oxide Nanoparticles Enhance MRI T2 Contrast
Ref: E-314-2013/0 | Updated: Sep 17, 2015
Ultra-sensitive Diagnostic Detects fg/mL-pg/mL Pathogen/Disease Protein by Visual Color Change
Ref: E-167-2014/0 | Updated: Sep 17, 2015
T-cell Chimeric Receptors of TSLPR for Diagnosis and Immunotherapy of Cancer
Ref: E-008-2014/0 | Updated: Nov 20, 2014
Chemotherapeutic Anti-cancer Agents
Ref: E-027-2014/0 | Updated: Oct 27, 2014
Photo-Controlled Removal of Targets In Vitro and In Vivo
Ref: E-209-2014/0 | Updated: Oct 9, 2014
A Current Amplifier for Local Coil Pre-amplification of NMR/MRI Signals
Ref: E-122-2014/0 | Updated: Sep 9, 2015
Use of Small Molecules to Treat PARP1-deficient Cancers
Ref: E-039-2014/0 | Updated: Dec 16, 2015
Chimeric Receptors Targeting CD-19
Ref: E-042-2014/0 | Updated: Oct 28, 2014
A Novel X-ray Grating to Enhance Phase Contrast Imaging
Ref: E-114-2013/0 | Updated: Sep 9, 2015


Subscribe to Technologies related to Cancer